News

The U.S. Food and Drug Administration has approved Arcutis Biotherapeutics' Zoryve (roflumilast) topical foam 0.3% for the ...
Grace Foam Solutions (GFS), a spray foam distribution and installation company in Wesson, was recently invited to join ...